Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Insulin Resistance × Exercise Test × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6 Colorectal Neoplasms 5 Lung Neoplasms 4 Prostatic Neoplasms 3 Motor Activity 2 Hodgkin Disease 2 Hematopoietic and Lymphoid System Neoplasm 2 Urinary Bladder Neoplasms 1 Sleep Wake Disorders 1 Sedentary Behavior 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Pathologically Proven Gastrointestinal Malignancy 1 Obesity 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Insulin Resistance 1 Inflammatory Breast Neoplasms 1 Hematopoietic and Lymphatic System Neoplasm 1 Fatigue 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Depression 1 Colonic Neoplasms 1 Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1 Cardiotoxicity 1 Carcinoma, Transitional Cell 1

Interventions

Metformin 12 Exercise 6 Inositol 4 Water 2 Preoperative Exercise 2 Insulin 2 High-Intensity Interval Training 2 Ethinyl Estradiol 2 Cyproterone Acetate 2 Acupuncture Therapy 2 ziprasidone 1 adrenosterone 1 Tablets 1 Standard of Care 1 Resistance Training 1 Pioglitazone 1 Phlebotomy 1 Olanzapine 1 Magnesium Oxide 1 Magnesium 1 Ketones 1 Human Growth Hormone 1 Health Planning Guidelines 1 Growth Hormone 1 Folic Acid 1 Exercise Test 1 Endurance Training 1 Electroacupuncture 1 Diet, Reducing 1 Diet, Paleolithic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05215223 2023-10-17

WBV

Cairo University

Phase NA Completed

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡